Pharma Mar Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	48.87	17.82	63.24	60.02	149.81	113.35
Short-Term Investments	118.99	149.41	91.29	102.54	32.61	88.53
Cash & Short-Term Investments	167.85	167.22	154.53	162.56	182.42	201.88
Cash Growth	19.18%	8.22%	-4.94%	-10.89%	-9.64%	3.26%
Accounts Receivable	39.95	39.05	34.27	27.2	29.32	50.91
Other Receivables	-	0.36	0.41	0.35	-	-
Receivables	39.95	39.41	34.68	27.55	29.32	50.91
Inventory	53.12	50.64	50.89	39.29	27.75	10.54
Prepaid Expenses	1.29	1.5	1.74	2.92	5.98	3.91
Other Current Assets	11.24	24.65	8.41	20.28	29.71	28
Total Current Assets	273.45	283.42	250.25	252.6	275.18	295.23
Property, Plant & Equipment	59.66	60.12	57.75	34.54	33.23	26.9
Long-Term Investments	0.63	0.58	2.46	6.06	49.4	10.72
Other Intangible Assets	3.79	1.36	1	1.23	1.19	1.13
Long-Term Deferred Tax Assets	46.89	46.55	36.01	31.47	30.53	27.75
Long-Term Deferred Charges	-	2.19	-	0.7	1.4	2.11
Other Long-Term Assets	0.85	0.87	2.18	13.91	2.33	4.55
Total Assets	385.26	395.08	349.64	340.52	393.26	368.39
Accounts Payable	43.83	40.91	38.81	29.17	27.49	26.93
Accrued Expenses	5.59	14.31	13.57	12.39	10.44	9.5
Short-Term Debt	-	4.79	4.72	6.46	4.48	3.84
Current Portion of Long-Term Debt	11.53	6.24	3.25	6.37	8.64	8.37
Current Portion of Leases	1.53	1.71	1.88	1.98	1.61	1.82
Current Unearned Revenue	5.53	7.74	5.38	25.93	26.11	30.89
Other Current Liabilities	21.22	18.18	15.08	13.59	18.54	4.99
Total Current Liabilities	89.23	93.88	82.69	95.89	97.32	86.35
Long-Term Debt	33.16	35.55	39.87	27.04	25.88	33.39
Long-Term Leases	1.31	1.13	1.36	1.83	2.01	1.92
Long-Term Unearned Revenue	11.84	12.64	17.17	22.14	44.9	68.63
Other Long-Term Liabilities	0.05	0.05	0.19	0.19	0.19	0.19
Total Liabilities	135.59	143.25	141.29	147.08	170.3	190.47
Common Stock	10.8	10.8	10.93	11.01	11.01	11.01
Additional Paid-In Capital	45.91	45.91	59.86	71.28	71.28	71.28
Retained Earnings	235.43	233.83	168.38	142.22	156.51	121.29
Treasury Stock	-42.49	-38.72	-30.83	-31.09	-15.87	-25.68
Comprehensive Income & Other	0.02	0.02	0.02	0.02	0.02	0.02
Total Common Equity	249.67	251.83	208.36	193.44	222.96	177.92
Shareholders' Equity	249.67	251.83	208.36	193.44	222.96	177.92
Total Liabilities & Equity	385.26	395.08	349.64	340.52	393.26	368.39
Total Debt	47.54	49.42	51.08	43.67	42.63	49.33
Net Cash (Debt)	120.32	117.81	103.45	118.89	139.79	152.55
Net Cash Growth	35.33%	13.88%	-12.99%	-14.95%	-8.36%	9.86%
Net Cash Per Share	6.93	6.75	5.89	6.64	7.74	8.44
Filing Date Shares Outstanding	17.36	17.36	17.57	17.64	18.11	18.01
Total Common Shares Outstanding	17.36	17.36	17.57	17.64	18.11	18.01
Working Capital	184.23	189.54	167.55	156.71	177.86	208.89
Book Value Per Share	14.38	14.51	11.86	10.97	12.31	9.88
Tangible Book Value	245.88	250.48	207.36	192.2	221.77	176.79
Tangible Book Value Per Share	14.16	14.43	11.80	10.90	12.25	9.82
Land	-	37.86	36.04	29.04	29.04	22.59
Machinery	-	64.18	60.68	43.28	27.87	24.32